vs

Side-by-side financial comparison of Inogen Inc (INGN) and TSS, Inc. (TSSI). Click either name above to swap in a different company.

Inogen Inc is the larger business by last-quarter revenue ($68.6M vs $60.9M, roughly 1.1× TSS, Inc.). On growth, TSS, Inc. posted the faster year-over-year revenue change (21.8% vs 3.4%). TSS, Inc. produced more free cash flow last quarter ($15.8M vs $-1.9M). Over the past eight quarters, TSS, Inc.'s revenue compounded faster (95.8% CAGR vs 4.2%).

Inogen Inc is a medical technology firm specializing in the development, production and distribution of portable oxygen concentrators and associated respiratory care products. It caters primarily to patients with chronic respiratory conditions needing long-term oxygen therapy across North America, Europe and other global markets, focusing on home care and ambulatory patient segments to enhance users' quality of life.

INGN vs TSSI — Head-to-Head

Bigger by revenue
INGN
INGN
1.1× larger
INGN
$68.6M
$60.9M
TSSI
Growing faster (revenue YoY)
TSSI
TSSI
+18.3% gap
TSSI
21.8%
3.4%
INGN
More free cash flow
TSSI
TSSI
$17.7M more FCF
TSSI
$15.8M
$-1.9M
INGN
Faster 2-yr revenue CAGR
TSSI
TSSI
Annualised
TSSI
95.8%
4.2%
INGN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
INGN
INGN
TSSI
TSSI
Revenue
$68.6M
$60.9M
Net Profit
$12.2M
Gross Margin
51.4%
17.6%
Operating Margin
-13.6%
1.5%
Net Margin
20.0%
Revenue YoY
3.4%
21.8%
Net Profit YoY
535.7%
EPS (diluted)
$-0.26
$0.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INGN
INGN
TSSI
TSSI
Q4 25
$68.6M
$60.9M
Q3 25
$79.1M
$41.9M
Q2 25
$79.2M
$44.0M
Q1 25
$68.5M
$99.0M
Q4 24
$66.3M
$50.0M
Q3 24
$74.9M
$70.1M
Q2 24
$74.4M
$12.2M
Q1 24
$63.1M
$15.9M
Net Profit
INGN
INGN
TSSI
TSSI
Q4 25
$12.2M
Q3 25
$-5.3M
$-1.5M
Q2 25
$-4.2M
$1.5M
Q1 25
$-6.2M
$3.0M
Q4 24
$1.9M
Q3 24
$-6.0M
$2.6M
Q2 24
$-5.6M
$1.4M
Q1 24
$-14.6M
$15.0K
Gross Margin
INGN
INGN
TSSI
TSSI
Q4 25
51.4%
17.6%
Q3 25
52.2%
11.1%
Q2 25
52.2%
17.8%
Q1 25
53.1%
9.3%
Q4 24
54.7%
14.4%
Q3 24
55.2%
11.3%
Q2 24
57.4%
37.3%
Q1 24
54.5%
17.1%
Operating Margin
INGN
INGN
TSSI
TSSI
Q4 25
-13.6%
1.5%
Q3 25
-9.0%
-2.2%
Q2 25
-7.7%
5.1%
Q1 25
-11.2%
4.2%
Q4 24
-17.2%
0.0%
Q3 24
-10.4%
5.4%
Q2 24
-9.5%
14.0%
Q1 24
-25.8%
1.6%
Net Margin
INGN
INGN
TSSI
TSSI
Q4 25
20.0%
Q3 25
-6.7%
-3.6%
Q2 25
-5.2%
3.4%
Q1 25
-9.0%
3.0%
Q4 24
3.8%
Q3 24
-8.0%
3.8%
Q2 24
-7.5%
11.5%
Q1 24
-23.1%
0.1%
EPS (diluted)
INGN
INGN
TSSI
TSSI
Q4 25
$-0.26
$0.44
Q3 25
$-0.20
$-0.06
Q2 25
$-0.15
$0.06
Q1 25
$-0.25
$0.12
Q4 24
$-0.41
$0.08
Q3 24
$-0.25
$0.10
Q2 24
$-0.24
$0.06
Q1 24
$-0.62
$0.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INGN
INGN
TSSI
TSSI
Cash + ST InvestmentsLiquidity on hand
$103.7M
$85.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$192.2M
$76.6M
Total Assets
$298.6M
$184.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INGN
INGN
TSSI
TSSI
Q4 25
$103.7M
$85.5M
Q3 25
$106.5M
$70.7M
Q2 25
$103.7M
Q1 25
$118.9M
Q4 24
$113.8M
$23.2M
Q3 24
$105.7M
$46.4M
Q2 24
$97.9M
$8.3M
Q1 24
$107.4M
$14.4M
Stockholders' Equity
INGN
INGN
TSSI
TSSI
Q4 25
$192.2M
$76.6M
Q3 25
$197.2M
$63.4M
Q2 25
$199.5M
$9.5M
Q1 25
$198.0M
$9.4M
Q4 24
$173.9M
$7.1M
Q3 24
$185.4M
$7.7M
Q2 24
$187.6M
$5.2M
Q1 24
$191.9M
$3.7M
Total Assets
INGN
INGN
TSSI
TSSI
Q4 25
$298.6M
$184.9M
Q3 25
$307.0M
$165.4M
Q2 25
$312.0M
$139.5M
Q1 25
$308.4M
$113.5M
Q4 24
$296.2M
$96.6M
Q3 24
$306.2M
$67.3M
Q2 24
$308.9M
$28.9M
Q1 24
$315.6M
$26.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INGN
INGN
TSSI
TSSI
Operating Cash FlowLast quarter
$-943.0K
$16.3M
Free Cash FlowOCF − Capex
$-1.9M
$15.8M
FCF MarginFCF / Revenue
-2.8%
25.9%
Capex IntensityCapex / Revenue
1.4%
0.9%
Cash ConversionOCF / Net Profit
1.34×
TTM Free Cash FlowTrailing 4 quarters
$-13.7M
$2.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INGN
INGN
TSSI
TSSI
Q4 25
$-943.0K
$16.3M
Q3 25
$2.2M
$-18.4M
Q2 25
$4.3M
$16.3M
Q1 25
$-16.8M
$20.6M
Q4 24
$-3.0M
$-21.6M
Q3 24
$7.0M
$38.6M
Q2 24
$6.7M
$-4.3M
Q1 24
$-4.7M
$2.6M
Free Cash Flow
INGN
INGN
TSSI
TSSI
Q4 25
$-1.9M
$15.8M
Q3 25
$1.6M
$-24.9M
Q2 25
$3.7M
$5.4M
Q1 25
$-17.1M
$5.8M
Q4 24
$-3.3M
$-28.4M
Q3 24
$5.3M
$38.6M
Q2 24
$6.6M
$-6.0M
Q1 24
$-6.1M
$2.6M
FCF Margin
INGN
INGN
TSSI
TSSI
Q4 25
-2.8%
25.9%
Q3 25
2.0%
-59.3%
Q2 25
4.6%
12.3%
Q1 25
-24.9%
5.8%
Q4 24
-5.0%
-56.7%
Q3 24
7.1%
55.1%
Q2 24
8.9%
-49.4%
Q1 24
-9.6%
16.4%
Capex Intensity
INGN
INGN
TSSI
TSSI
Q4 25
1.4%
0.9%
Q3 25
0.7%
15.3%
Q2 25
0.9%
24.8%
Q1 25
0.4%
15.0%
Q4 24
0.5%
13.4%
Q3 24
2.2%
0.1%
Q2 24
0.1%
13.8%
Q1 24
2.1%
0.2%
Cash Conversion
INGN
INGN
TSSI
TSSI
Q4 25
1.34×
Q3 25
Q2 25
11.02×
Q1 25
6.93×
Q4 24
-11.32×
Q3 24
14.60×
Q2 24
-3.09×
Q1 24
176.40×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

INGN
INGN

Other$36.1M53%
Non Us$32.5M47%

TSSI
TSSI

Procurement Revenues Segment$43.2M71%
System Integration Services Segment$14.2M23%
Facilities Segment$3.5M6%

Related Comparisons